Baylor Scott & White-Temple

Dr. Timothy Mixon, left, cardiac interventionalist at Baylor Scott & White-Temple, talks with his patient Dennis Herbert. Herbert had a transcatheter aortic valve replacement, TAVR, procedure last week.

Last week, the Food and Drug Administration approved a minimally invasive treatment for people who have aortic stenosis, the narrowing of the aortic valve.

Aortic stenosis is a common but serious heart valve disease. Up until the development of TAVR, transcatheter aortic valve replacement, the only treatment available was open heart surgery.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.